SPONSOR
Rutgers, The State University of New Jersey
Total Trials
19
Recruiting
19
Phases
Phase 1, Phase 2, Phase 2, Phase 3, Phase 3, EARLY_Phase 1
Conditions studied: AggressionSelf-injurious BehaviorProblem BehaviorSelf InjuryTobacco Use DisorderMindfulnessGuanfacineOpioid Use DisorderHereditary CancerGenetic Testing
Rutgers, The State University of New Jersey is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Aggression, Self-injurious Behavior, Problem Behavior, Self Injury.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Rutgers, The State University of New Jersey
How many clinical trials has Rutgers, The State University of New Jersey sponsored?
ClinicalMetric currently tracks 19 clinical trials sponsored by Rutgers, The State University of New Jersey, of which 19 are actively recruiting participants. These trials cover conditions including Aggression, Self-injurious Behavior, Problem Behavior. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rutgers, The State University of New Jersey research focus on?
Rutgers, The State University of New Jersey clinical trials span Aggression, Self-injurious Behavior, Problem Behavior, Self Injury, Tobacco Use Disorder, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rutgers, The State University of New Jersey clinical trial?
To participate in a Rutgers, The State University of New Jersey trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rutgers, The State University of New Jersey trials with current recruitment status updated daily.
Clinical Trials by Rutgers, The State University of New Jersey
NCT04045600
Recruiting
Refinements of Functional Communication Training
Aggression
NCT05925101
Recruiting
Basic and Applied Research on Extinction Bursts
Problem Behavior
NCT07812753
Recruiting
Modulating Neural Mechanisms of Reward Processing in Tobacco Users
Tobacco Use Disorder
NCT06642181 Phase 1
Recruiting
Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder
Mindfulness
NCT06073626
Recruiting
Addressing Genomic Disparities in Cancer Survivors
Hereditary Cancer
NCT06546085
Recruiting
Extracellular Vesicles, Insulin Action, and Exercise
Type 2 Diabetes
NCT05559164 Phase 2
Recruiting
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Cardiac Toxicity
NCT07675499 Phase 2, Phase 3
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
Type 2 Diabetes
NCT06968832
Recruiting
Project COMET: Massed Prolonged Exposure for PTSD and SUD
Posttraumatic Stress Disorder (PTSD)
NCT06336590
Recruiting
Student Exercise and Sleep Timing Study - Part 2
Sleep
NCT05084196 Phase 3
Recruiting
Melatonin for Prevention of Kidney Injury
Acute Kidney Injury
NCT06663813
Recruiting
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
Type 2 Diabetes
NCT07060495 Phase 3
Recruiting
RADA16 for Adult Tonsillectomy
Postoperative Pain
NCT02688517
Recruiting
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Malignant Neoplasm
NCT06797219
Recruiting
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
Intraventricular Hemorrhage of Prematurity
NCT06072963 Phase 2
Recruiting
COMMETS- Combination MCI Metabolic Syndrome
Alzheimer Disease
NCT07643012
Recruiting
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
Endometrial Cancer
NCT04211259 EARLY_Phase 1
Recruiting
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Plasma Cell Myeloma
NCT05766280
Recruiting
Internet Assisted Career-Oriented Soft-skills Training for Transition Age Youth with Mental Health Conditions
Mental Health Wellness 1
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology